The National Development and Reform Commission organized a symposium on the assessment of costs of price disorder competition.
The National Development and Reform Commission, together with relevant departments and industry associations, convened a meeting to study and formulate standards for determining costs related to price disorderly competition.
On November 24th, the National Development and Reform Commission, together with relevant departments and industry associations, held a meeting to discuss and formulate standards for determining the costs of price disorderly competition and other related work. The meeting pointed out that the problem of price disorderly competition in some industries is still prominent, with some companies failing to implement the requirements for regulating price competition behavior, and even engaging in behaviors that disrupt market price order. The National Development and Reform Commission will continue to work with relevant departments to address the issue of price disorderly competition, maintain a good market price order, and support high-quality development.
Related Articles

Lowering interest rates further is a high hurdle! Reserve Bank of New Zealand Governor strengthens signal of the end of loose monetary policy.

S&P downgrades USDT stability rating to the lowest level, warning of insufficient collateral risk.

The Bank of Korea has maintained its interest rate unchanged for the fourth consecutive time, with stable growth coexisting with ongoing financial risks.
Lowering interest rates further is a high hurdle! Reserve Bank of New Zealand Governor strengthens signal of the end of loose monetary policy.

S&P downgrades USDT stability rating to the lowest level, warning of insufficient collateral risk.

The Bank of Korea has maintained its interest rate unchanged for the fourth consecutive time, with stable growth coexisting with ongoing financial risks.

RECOMMEND

Hong Kong Stock Buyback Wave Persists, 247 Listed Companies Repurchase Over HKD 150 Billion This Year
27/11/2025

Mingyu Pharmaceutical Files With HKEX: Ongoing Net Losses Since Inception, No Revenue From Commercial Product Sales
27/11/2025

“Affordability Crisis”! Consumer Confidence Falls To Second Lowest Since The Pandemic, U.S. Retail Slumps
27/11/2025


